Concepedia

Emma Hajaj

EH

Statistics

Publications

10

Citations

358

H-Index

10

Active since

2018

Affiliations

Hadassah Medical Center(Current)

Hebrew University of Jerusalem

Weizmann Institute of Science

St. Marianna University School of Medicine

Broad Institute

Emma Hajaj is an author at Hadassah Medical Center specializing in cancer therapeutics, medicine, and oncology.

ORCID

Top concepts

Publications per year

2018–2024

10

Publications

10

<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment

Martino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj et al. · Proceedings of the National Academy of Sciences · 2021 · 111 citations · Full text

Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer

Matthew D. Galsky, Xiangnan Guan, Deepali Rishipathak et al. · Cell Reports Medicine · 2024 · 48 citations · Full text

, , +17

Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study

Reut Hadash‐Bengad, Emma Hajaj, Shiri Klein et al. · Frontiers in Oncology · 2020 · 42 citations · Full text

SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint

Emma Hajaj, Galit Eisenberg, Shiri Klein et al. · eLife · 2020 · 39 citations · Full text

Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity <i>In Vivo</i>

Galit Eisenberg, Roni Engelstein, Anat Geiger-Maor et al. · Cancer Immunology Research · 2018 · 29 citations

Rows per page

1–5 of 10